Site Navigation:
State Profiles
Maryland
In 2009, Maryland-based federal agencies and laboratories received a federal R&D investment of $15.9 billion. They leveraged that investment via their technology transfer efforts to address societal needs, promote economic development and growth, and enhance U.S. competitiveness. From defense to life sciences to energy to agriculture, Maryland-based federal agencies and labs are meeting the technology transfer mission envisioned by Congress.
|
Federal Obligations for R&D in Maryland, 2009 ($thousands)
|
| Agency |
Total |
| All Agencies |
15,970,508 |
| Dept. of Agriculture |
201,631 |
| Dept. of Commerce |
543,771 |
| Dept. of Defense |
5,070,627 |
| Dept. of Energy |
42,224 |
| Dept. of Health and Human Services |
8,829,297 |
| Dept. of Homeland Security |
100,042 |
| Dept. of Interior |
61,906 |
| Dept. of Transportation |
22,161 |
| Environmental Protection Agency |
16,489 |
| NASA |
934,469 |
| National Science Foundation |
147,891 |
|
Source: NSF Science and Engineering Profiles
|
Technology Transfer Success Stories
National Cancer Institute Research Leads to HPV Vaccine
Gardasil™, a vaccine developed by Merck & Company to prevent human papillomavirus (HPV) infection, the primary cause of cervical cancer, is a major advancement in cancer prevention and the protection of women's health. Key elements of the technology for Gardasil™ originated from HPV research conducted at the National Institutes of Health's National Cancer Institute in Bethesda, Maryland. Clinical studies conducted in 13 countries, including the U.S., found it to be 100% effective in preventing HPV16- and HPV18-related cervical cancers.
Army Scientists Combat Terrorism
Recognizing the need for a comprehensive aerosol control platform suitable for a variety of agents, animal species, and aerosol forms in the event of a bioterrorism attack, researchers from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Maryland, created the Automated Inhalation Toxicology Exposure System. The system allows for experimental infection by inhalation, a process that is critical in developing medical countermeasures for biological threats. The patented technology, which was later named the AeroMP upon commercialization, greatly benefits the civilian and military communities in combatting the dangers of influenza, poxvirus, tularemia, and anthrax.
A patent license was given to Biaera Technologies located in Hagerstown, Maryland where continued development of new technologies for aerobiology research is conducted.
Connect with Maryland Laboratories
To learn more about, and connect with, Maryland's FLC member laboratories, visit the Maryland Laboratories web page. The web-based, searchable database displays laboratory profiles with information such as contacts, areas of expertise, laboratory history, website links, and more.
Contact an FLC Representative in Your Region
Dr. Courtney Silverthorn
SAIC-Frederick, Inc.
Phone: 301-846-6316
Email:
silverthorncf@mail.nih.gov
|
